Propofol is regarded currently as the most suitable anaesthetic agent for total i.v. anaesthesia (TIVA); it allows for rapid changes in anaesthetic depth and a rapid, clear-headed recovery [1] . Also, low contextsensitive half-time [2] makes it theoretically the best available agent for long procedures under TIVA. Furthermore, propofol attenuates airway reflexes to the extent that the laryngeal mask airway (LMA) may be positioned easily without neuromuscular block [3] . Propofol may even allow for insertion of a tracheal tube (TT) without neuromuscular block [4, 5] . Neuromuscular blocking drugs are used widely in anaesthesia in association with controlled ventilation when the surgical site does not require muscular paralysis. This may increase the danger of awareness and expose patients to risks of ventilatory failure in the event of equipment malfunction or inadvertent disconnection from the ventilator circuit.
It was therefore decided to evaluate the practicality of TIVA using the LMA as an alternative airway management device to the TT in peripheral orthopaedic surgical procedures, during controlled ventilation using propofol and fentanyl. In order to study the effect of neuromuscular blocking agents on anaesthetic requirements and the practicality of TIVA, both the LMA and TT were studied with and without neuromuscular block. Furthermore, a comparison was made between the LMA and TT on the basis of the effect of neuromuscular blockers on the feasibility of the technique. Finally, the effect of the different anaesthetic techniques on serum concentrations of catecholamines was also studied.
Patients and methods
We studied ASA I patients undergoing orthopaedic surgery. The study was approved by the University of Cape Town Ethics Committee and informed consent was obtained from all patients.
Premedication comprised oral temazepam 20-30 mg, 2 h before operation. An i.v. cannula and a 22-gauge arterial cannula were inserted under local anaesthesia and a 10-ml arterial blood sample was obtained for measurement of plasma concentrations of catecholamines. Patients were allocated randomly to one of four groups. All groups received a standard induction (see below), and the individual groups were treated as described below.
Group 1 received vecuronium O.lmgkg" 1 , the trachea was intubated and the lungs ventilated mechanically throughout the procedure. Neuromuscular block was monitored using the Relaxograph and maintained at Tl>90% depression, with incremental boluses of vecuronium 1 mg as required. At the end of the procedure, residual neuromuscular block was antagonized with neostigmine and glycopyrronium. Intubation in group 2 was undertaken using fentanyl and propofol alone, with no neuromuscular block and the lungs were ventilated mechanically. In group 3 an LMA was inserted under propofol anaesthesia and neuromuscular blockers administered as in group 1. Patients in group 4 were treated as those in group 2 except that they received an LMA instead of a TT.
All subjects received glycopyrronium 0.2 mg followed by fentanyl 2 ng kg" 1 2 min before induction. Induction was performed with propofol administered from a standard syringe driver (Ohmeda 900) at a rate of 600 ml h" 1 (10 ml min" 1 ), until the eyelash reflex was lost and then another 2 ml was infused. At this point patients in groups 1 and 3 received vecuronium O.lmgkg" 1 and the other subjects received an equivalent volume of saline; propofol was continued at a rate of 10 mg kg" 1 h" 1 for 3 min until intubation or placement of the LMA had been performed. In groups 2 and 4 insertion of the airway device (TT or LMA) took place immediately on completion of induction of anaesthesia. In all cases the anaesthetist performing the intubation and conducting the remainder of the anaesthetic was blinded as to the use of neuromuscular blockers. In all patients anaesthesia was maintained with a continuous infusion of propofol on a step-down regimen as follows: lOmgkg" 1^1 for 15 min (including preintubation time), 8 mg kg" 1 h~' for 15 min and then a target rate of 6 mg kg" 1 h" 1 , the precise rate being determined by clinical signs of depth of anaesthesia. These signs were as follows: purposeful or non-purposeful movement, change in arterial pressure greater than 20 % of the baseline value, or change in heart rate greater than 20 % of baseline (if accompanied by a similar trend in arterial pressure), sweating or lacrimation. Alterations in anaesthetic depth were made in a stepwise manner as follows: if the patient was too lightly anaesthetized (see above), a bolus of propofol 0.5 mg kg" 1 was administered, followed by a second bolus if needed within 5 min. After two such boluses, the infusion rate was increased by 2 mgkg" 1 h"
1
. Further increases were made in this manner until a stable state was established. If the patient was too deeply anaesthetized, as judged by a decrease in heart rate, arterial pressure, or both, of > 20 % of baseline in the absence of other causes of hypotension, the infusion rate was stepped down by 2 mg kg" 1 h" 1 until satisfactory depth was established, at 10-min intervals. All patients received fentanyl 1 ug kg" 1 repeated at 30-min intervals until the end of the procedure; the last dose was not given within 15 min of the anticipated end of the procedure. The inhaled gas mixture was oxygen in air, with an FI OJ of 30 % or greater as necessary to maintain arterial saturation greater than 95 %. All subjects' lungs were ventilated mechanically with a tidal volume of 7 ml kg" 1 at a rate necessary to maintain expired PE CC>2 at 4-5 kPa. At the end of the procedure, in groups 1 and 3, neuromuscular block was antagonized and after adequate tidal volumes were attained, the airway maintenance device was removed when the patient was sufficiently wide awake to maintain an unsupported airway. In the two other groups the airway maintenance device was removed when the patient could maintain an unsupported airway.
The cardiovascular changes during the induction sequence were noted. Intubation conditions were assessed in groups 1 and 2 as follows: at laryngoscopy, the position of the vocal cords was noted and recorded on the following scale: 1 = cords fully open and stationary, 2 = cords partially open and stationary, 3 = cords partially open and moving and 4 = cords closely opposed. In group 2, suxamethonium 1 mg kg" 1 was administered before intubation if the vocal cord score was 3 or 4. After insertion of the TT or LMA, the insertion conditions were assessed as follows: 1 = device easily inserted, 2 = device inserted with slight resistance, 3 = device inserted with difficulty, or repeated attempts required and 4 = insertion abandoned. The response of the patient was graded as follows: 1 = no response, 2 = slight bucking, 3 = coughing and 4 = gross body movements. In all four groups cardiovascular status was recorded every minute for 5 min after completion of intubation and thereafter at 5-min intervals.
Ventilatory function was monitored by recording peak airway pressures, end-tidal carbon dioxide partial pressures and airway leaks at 10-min intervals. The latter was monitored by gentle auscultation of the neck adjacent to the thyroid cartilage.
Anaesthetic requirements were noted by recording the infusion rates and total dose requirements (mg kg" 1 h" 1 ) of propofol. Baseline plasma catecholamines were measured from the arterial cannula 5 min after insertion of the radial artery cannula. Subsequent samples were obtained after induction and at 2 and 5 min after intubation. Concentrations were measured by electrochemical detection after separation with reverse phase HPLC with dihydrobenzylamine as internal standard using a method described previously [6] . The lower limit of sensitivity of this method is 20 pg ml" 1 for both noradrenaline and adrenaline and the coefficient of variation of the assay was 8.6 % for noradrenaline (mean standard concentration 861.5 pg ml" 1 ) and 5.0% for adrenaline (mean standard concentration 1047.0 pg ml" 1 ). At the end of the procedure, blood samples were obtained before extubation and at 2 and 5 min after removing the TT or LMA, and cardiovascular data were recorded at the same times as for the intubation response. During operation ventilatory frequency and tidal volume were recorded at 5-min intervals and blood-gas estimations performed at 30-min intervals. Oxygen saturation and end-tidal Pco 2 were monitored continuously. Failure of any technique at any time (e.g. inability to maintain adequate ventilation with the LMA, unresponsive hypotension) resulted in conclusion of the study in that subject, and the use of alternative anaesthetic techniques as indicated. Such withdrawal was regarded as a technical failure, but did not result in exclusion of the patient from the study.
In the recovery room, cardiovascular data were recorded at 5-min intervals for the first hour, and oxygen saturation was monitored continuously. The incidence of nausea and vomiting in the four groups was noted and the time taken to full recovery, as judged by ability to remember date of birth and the day's date. At a postoperative visit within 24 h of the conclusion of the study, every patient was questioned regarding recall of operative events.
Numerical data were analysed by analysis of variance with multiple range testing to identify significantly different groups. Qualitative data were compared using chi-square analysis, and where nonparametric scoring systems were used, the KruskalWallis non-parametric analysis of variance was used. Categorical data were analysed using chi-square and Fisher's exact tests as appropriate. All statistical tests were conducted using Statgraphics version 5 statistical package running on an IBM-compatible 386 machine under MS-DOS version 6. The null hypothesis was rejected at P < 0.05. 125 2 were significantly greater than those in group 1, and insertion response score was higher in group 2 compared with groups 1, 3 and 4. In 11 patients in group 2 laryngoscopy scores were greater than 2 and this necessitated suxamethonium before intubation. Consequently, insertion conditions were similar for all groups. Haemodynamic data for the first 10 min after insertion of the airway management device are shown in figures 1 and 2. Groups 1 and 2 had significantly higher heart rates and mean arterial pressures than groups 3 and 4 for varying periods up to 5 min after intubation. Baseline plasma catecholamine concentrations were not significantly different between groups. Changes in plasma concentrations of catecholamines during and after induction and extubation are shown in figures 3 and 4. No consistent within-or between-group trends could be demonstrated. There was no significant increase in catecholamine concentrations in response to either TT or LMA insertion. Table 5 shows data on anaesthetic requirements. There was no significant difference between groups in induction dose or total dose. Groups 2 and 4 required significantly more bolus doses of propofol than group 1, and group 3 required significantly fewer boluses than group 2. The percentage of drug given as boluses was relatively small (10.1 %, 17.4 %, 11.8% and 17.0% in groups 1^, respectively). The commonest indication for bolus administration in groups 1, 3 and 4 was a change in heart rate or arterial pressure (table 6). Patients in group 2 required significantly more interventions for coughing than groups 1, 3 and 4; groups 2 and 4 required more boluses for movement than groups 1 and 3. The total anaesthetic requirement was similar in all groups. However, when groups 1 and 3 (with neuromuscular block) were pooled and compared with groups 2 and 4, the total dose of propofol Table 5 Anaesthetic requirements and recovery times (mean (SD)). Significant differences (P < 0.05): * group 1 compared with groups 2 and 4; f group 3 compared with group 2 administered was found to be significantly higher in the non-paralysed group (11.48 (SD 3.2) vs 9.99 gg In group 3 there was minor difficulty with laryngeal mask placement with a small leak in three patients. In group 4 one patient had a mild degree of laryngospasm, one had persistent hiccup, one laryngeal mask had to be repositioned and there were two minor leaks. None of these minor events required substitution of the LMA with a TT. There were no significant differences between mean peak airway pressures in groups 3 and 4 (13.7 (3.6) vs 13.9 (2.5) cm H 2 O). No patient required an Fi O2 > 0.40 in order to maintain oxygen saturation > 95 %.
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There were no significant differences in extubation time or time to full recovery in the four groups (table  5) , and no correlation between total dose and full recovery time. Four patients had pain on full recovery, and none had nausea or vomiting within 30 min of arousal. One patient in each of groups 1-3, and two in group 4 shivered persistently during the recovery period. There were no cases of any degree of recall which could be attributed to conscious awareness.
Discussion
We have shown that the LMA was a highly effective alternative airway compared with the TT during TIVA with controlled ventilation, propofol and fentanyl. Although the study had to be concluded in one patient because of unresponsive hypotension, the technique was found to be safe in this population of patients. There were very few difficulties with the LMA, in contrast with the TT, where a high proportion of patients in group 2 required suxamethonium to facilitate intubation, despite reports to the effect that the trachea may be intubated without neuromuscular block after propofol [4, 5, 7] .
The LMA groups exhibited greater haemodynamic stability for the 5 min after insertion of the airway management device. This is in agreement with other studies using inhalation anaesthesia [8, 9] . The absence of changes in catecholamines in association with insertion of the TT is consistent with other studies in which propofol has been used for induction. In contrast with most previous studies, we used a propofol infusion throughout the induction sequence. In a previous study from this hospital [10] an increase in plasma adrenaline occurred only at 1 min after intubation. It is possible that such a transient elevation could have abated by 2 min in the present study. It has been shown previously that insertion of the LMA is associated with minimal changes in catecholamine concentrations [9] . Baseline concentrations of catecholamines may have been slightly elevated after insertion of the arterial cannula in our study, but they were within the normal range for our laboratory in all groups and the effect is likely to have been small. Any differences in propofol dose requirements related to the use of neuromuscular blockers may have one of three implications. First, the TT may require deeper anaesthesia than the LMA in order for it to be tolerated. Second, the use of blockers abolishes movement as a useful indicator of anaesthetic depth and this may place paralysed patients at risk of awareness. Third, neuromuscular blockers may alter the anaesthetic effectiveness of propofol and thus change the depth of anaesthesia associated with any given plasma concentration. Evidence to the effect that blockers alter MAC with inhalation anaesthesia is conflicting [11, 12] . One recent study presented EEG evidence that pancuronium reduces isoflurane requirements in dogs [13] . There are no similar data regarding TIVA.
It is our impression that the second of these options is the most likely explanation of the small difference in propofol dose requirements between the neuromuscular blocker and non-blocker groups. Although overall anaesthetic requirements did not differ in the four groups, the increased dose requirement in the pooled non-neuromuscular blocker groups (groups 2 and 4) may represent a danger of under-dosing patients in the neuromuscular blocker groups. Mean propofol consumption in the four groups suggests that our infusion regimen was too low for this particular group. However, anaesthetic depth was adjusted easily by bolus administration of propofol. There were more interventions in the form of bolus administration of propofol in the nonparalysed groups compared with the paralysed groups. Analysis of the reasons for these interventions gave some insight into the clinical feasibility of the technique. Coughing generally interfered with surgery and made controlled ventilation difficult to manage. In contrast, movement not associated with coughing did not interfere with surgery or impair ventilation. Thus the increased number of boluses required in response to coughing in group 2 vs group 4 suggests that if neuromuscular blocking drugs are not used, the LMA is an easier airway management device during TIVA than the TT. Although there were no increased anaesthetic requirements if neuromuscular blockers were omitted while using the LMA, patients in group 4 required more interventions for movement than group 3. It is also noteworthy that the increased incidence of movement in group 4 did not make controlled ventilation more difficult to manage than in group 3 (further supported by the similar mean peak airway pressures). Moreover, movement provided an added indication of wakefulness, and suggests some benefit in the omission of neuromuscular blockers if the surgical site does not require paralysis. This is particularly relevant in routine clinical anaesthesia, where the average anaesthetist has no access to sophisticated indicators of intraoperative awareness, such as the processed EEG and evoked potentials, and must be guided by cardiovascular responses and movement.
Although there were differences in the number of bolus doses between groups, the relatively small percentage of drug administered as a bolus accounts for the absence of significant differences in total doses. Lacrimation and sweating were absent in this study; glycopyrronium 0.2 mg given to prevent bradycardia was probably inadequate to explain this finding, and it may be a feature of propofol anaesthesia.
